Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trials.
AuteursBorea R, Blondeaux E, Carmisciano L, Arecco L, Perachino M, Poggio F, Ruelle T, Luelli F, de Laurentiis M, Arpino G, Puglisi F, Fabi A, Gori S, Fregatti P, Lambertini M, Boni L, Del Mastro L
Antimicrobial resistance of bacteria isolated in a resource-limited region: the experience of the North Kivu Provincial Reference Laboratory in the Democratic Republic of the Congo.
AuteursBusha Tibasima E, Ndeba PM, Mseza B, Sy O, Ndeba SDA, Chalhoub H, Senga R, Kihemba K, Byl B, Vandenberg O